Last update:
HIV & AIDS news
Fraud detection critical to online health research, study finds
While online research is a useful way to reach people who may not take part in in-person studies, researchers are increasingly concerned that fake, automated and duplicate survey responses can reduce data quality and compromise ...
1 hour ago
0
0
Defective HIV copies explain most persistent traces in blood following treatment, study finds
Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives. However, a small portion of people experience detectable—and worrisome—traces of the virus that causes ...
Jun 8, 2026
0
19
HIV enters the brain and doesn't leave, drugs intended to reduce brain inflammation increase virus levels
HIV can damage the brain and cause memory and cognitive problems. And once HIV enters the brain, it does not leave.
Jun 8, 2026
0
4
Flu drugs show promise against cognitive decline
A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection, reports a new study led by Northwestern University that began with blood samples from people with HIV and ...
Jun 5, 2026
0
24
Popular GLP-1 drug may slow down biological aging, analysis indicates
Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease. Some researchers have ...
Jun 3, 2026
0
263
Deep South HIV prevention care has gaps where patients need it most
A recent University of Mississippi study has identified hundreds of counties in the South where HIV prevention and health care may not be keeping pace with the local needs, leaving communities without resources to address ...
Jun 3, 2026
0
3
The link between HIV and chronic pain
Over half of the people carrying HIV experience chronic pain at some point, which is difficult to treat. In a new JNeurosci paper, Hui-Lin Pan, from The University of Texas MD Anderson Cancer Center, and colleagues used mice ...
Jun 1, 2026
0
6
HIV in South Africa: Why rolling out a new shot will miss a critical group of men
The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026. Clinical trials showed close to 100% efficacy. The rollout, ...
Jun 1, 2026
0
4
Broccoli compounds may help repair HIV-linked gut damage, animal study suggests
For many people living with HIV, today's treatments can suppress the virus and dramatically improve health. But even when HIV is controlled, damage to the gut caused by the disease can persist, fueling chronic inflammation ...
May 25, 2026
0
18
Measuring shame through a combination of self-report, language and body posture may be clinically helpful
In stigmatized illnesses such as human immunodeficiency virus (HIV), shame and other negative self-conscious emotions are associated with suboptimal engagement in health care via stress and avoidance coping. However, shame ...
May 20, 2026
0
2
Adolescents' knowledge of legal capacity to independently consent linked to higher STI/HIV testing
A study has found that adolescents who were aware of their state's minor consent laws were more likely to seek and receive testing for HIV and other sexually transmitted infections, suggesting that teens' accurate knowledge ...
May 18, 2026
0
2
Children with HIV are living longer but face a rising obesity risk
Advances in HIV treatment have transformed what was once a fatal diagnosis into a manageable chronic condition. Today, children living with HIV are surviving—and increasingly thriving—into adolescence and adulthood.
May 13, 2026
0
4
HIV reveals more than 100 escape mutations against promising antibody therapies
Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily doses of antiretroviral drugs. In one recent clinical study of bNAbs identified ...
May 12, 2026
0
13
Small study hints that revving up immune cells might help fight HIV
Scientists are tweaking a powerful cancer therapy in hopes it could fight HIV instead, by supercharging patients' own immune cells.
May 12, 2026
0
6
Expanded TB screening in HIV wards fails to speed treatment, clinical trial shows
A clinical trial conducted in Tanzania and Mozambique and published in The Lancet Infectious Diseases concludes that expanding the use of molecular diagnostic tests on urine and stool samples, in addition to sputum, to detect ...
May 8, 2026
0
3
How HIV hijacks a cellular 'gateway' to infect resting immune cells
Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect resting immune cells. The discovery challenges a decades-old assumption in HIV biology, and opens new ...
May 6, 2026
0
7
Marker of biological aging linked to cognitive symptoms of depression
Blood tests measuring the aging of certain white blood cells can predict cognitive and mood-related symptoms of depression, rather than physical symptoms. These findings, published in The Journals of Gerontology, Series A: ...
May 4, 2026
0
8
FDA approves once-daily Idvynso tablet for treating HIV
The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen ...
May 1, 2026
0
24
The Bangui operation: A story of blood, science and biomedical exploitation
In the early 1990s, a secret HIV vaccine research project was carried out in the Central African Republic. The project didn't yield results and was hidden for many years. Today it sheds light on debates over clinical trials, ...
May 1, 2026
0
4
New HIV vaccine design trains immune system to hit shared viral target across variants
Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University, have developed a new vaccine strategy that has generated antibodies capable of neutralizing highly ...
Apr 29, 2026
0
18
HIV disrupts lung 'clock,' raising COPD and emphysema risk
People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked. FIU researchers have now uncovered a previously unknown mechanism that helps explain how HIV causes ...
Apr 25, 2026
0
7
Long-acting HIV shots appeal to many but uptake remains low
When it comes to HIV medication, many patients think they'd prefer an occasional injection over a daily pill, but uptake remains an issue, according to a Rutgers Health-led survey. When researchers surveyed 801 people living ...
Apr 23, 2026
0
6
How life-saving HIV therapy has contributed to increased rates of a sexually transmitted disease
A study in Health Economics uncovered an unintended consequence of a major medical breakthrough: while the availability of HIV treatments in the late 1990s dramatically improved survival, they also contributed to a resurgence ...
Apr 22, 2026
0
4
HIV's earliest immune battle leaves blood traces that forecast powerful antibodies years later
Some people living with HIV develop antibodies capable of neutralizing many different strains of the virus. New research links this to immune responses that occur early in infection. The findings, published in PLOS Pathogens, ...
Apr 21, 2026
0
11
